期刊
ANNALS OF THE RHEUMATIC DISEASES
卷 74, 期 11, 页码 2070-2075出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/annrheumdis-2013-204441
关键词
-
类别
资金
- National Key Basic Research Program of China (973 program) [2010CB529105, 2014CB541901]
- Program of International Science & Technology Cooperation of MOST [2010DFB34000]
- Major International Joint Research Project of NSFC [81120108020]
- National Natural Science Foundation of China [31270914, 81071940]
- Education Ministry's New Century Outstanding Talents Supporting Plan [NCET-12-0600]
- Beijing Natural Science Foundation [7122196]
Background Recently, our research group identified the non-deleted (functional) leucocyte immunoglobulin-like receptor A3 (LILRA3) as a new genetic risk for rheumatoid arthritis. Objectives To further investigate whether the functional LILRA3 is a new susceptibility factor for other autoimmune diseases for example, systemic lupus erythematosus (SLE) and primary Sjogren's syndrome (pSS). Methods The LILRA3 deletion polymorphism and its tagging single nucleotide polymorphism rs103294 were genotyped for 1099 patients with SLE, 403 patients with pSS and 2169 healthy controls. Association analyses were performed in whole dataset or clinical/serological subsets. The impact of LILRA3 on SLE activity and LILRA3 expression was evaluated. Results The functional LILRA3 conferred high susceptibility to both SLE (p=3.51x10(-7), OR=2.03) and pSS (p=1.40x10(-3), OR=2.32). It was associated with almost all the clinical/serological features in SLE, especially with leucopenia (p=4.09x10(-7), OR=2.19) and thrombocytopenia (p=1.68x10(-5), OR=1.70). In pSS, functional LILRA3 was specifically associated with leucopenia (p=4.39x10(-4), OR=3.25), anti-Ro/SSA-positive subphenotypes (p=4.54x10(-3), OR=2.34) and anti-La/SSB-positive subphenotypes (p=0.012, OR=2.49). Functional LILRA3 conferred higher disease activity in patients with SLE (p=0.044) and higher LILRA3 expression in both SLE (p=5.57x10(-8)) and pSS (p=1.49x10(-7)) than in controls. Conclusions Functional LILRA3 is a new susceptibility factor for SLE and pSS. It highly predisposes to certain phenotypes such as leucopenia and thrombocytopenia in SLE, and may confer increased disease activity in SLE and a higher risk of leucopenia and autoantibody-positive subphenotypes in pSS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据